Kite Pharma and Cell Design Labs said today they will partner to develop next-generation, precision-controlled chimeric antigen receptor (CAR) T-cell immunotherapy candidates using Cell Design Labs’ ...

BOSTON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Black Kite, the leader in third-party cyber risk intelligence, today announced that it was recognized with the “Red Dot” distinction for the 2024 Red Dot ...

Gilead Sciences and its Kite cell therapy subsidiary have agreed to acquire Cell Design Labs for up to approximately $567 million, in a deal designed to grow the buyers’ footprint in chimeric antigen ...

Aecon and Skyport are launching a contest to design Bermudian kites, with the winning designs set to “be incorporated into actual kites that will be suspended from the ceilings in the new terminal.” ...

FOSTER CITY, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and its cell therapy subsidiary Kite announced today that they have entered into a definitive ...

Kite shoppers in the city are spoilt for choice as the markets are flooded with kites in all sizes and shapes; those who don’t want to battle crowds or humidity are just logging in as the bazaars are ...

On Dec. 7, 2017, Gilead Sciences and its cell-therapy subsidiary Kite Pharma announced an agreement to acquire Cell Design Labs, a pre-clinical stage biotherapeutics company specializing in custom ...